3Gaughan DM, Mofenson LM, Hughes MD, et al. Osteo-necrosis of the hip (Legg-Calve-Perthes disease) in human immuno deficiency virus-infected children [J]. Pediatrics, 2002, 109(5): 74-77.
4Atsumi T, Yamano Y, Muraki M, et al. The bloed supply of the later- al epiphyseal arteries in Perthes'S disease [J]. J Bone Joint Surg, Br, 2000, 82(3): 392-398.
6Alpaslan AM, Aksov MC, Yazici M. Interruption of the blood sup- ply of femoral head: an experimental study on the pathogenesis of Legg-Calve-Perthes disease [J]. Arch Orthop Trauma Surg, 2007, 127(6): 485-491.
7Mehta JS, Conybeare ME, Hinves BL, et al. Protein C levels in pa- tients with Legg-Calv-Perthes disease: Is it a true deficiency?. [J]. JPediatr Orthop, 2006, 26(2): 200-203.
2Perry DC ,Hall M. The epidemiology and etiology of Perthes disease[J]. Orthop Clin North Am, 2011,42 (3) : 279-283.
3Daniel AB, Shah H, Kamath A, et al. Environmental tobacco and wood smoke increase the risk of Legg-Calve-Perthes disease [J]. Clin Orthop Rdat Res, 2012,470 (9) : 2369-2375.
4Catterall A. The natural history of Perthes' disease[J]. J Bone Joint Surg Br, 1971,53 ( 1 ) : 37-53.
5Herring JA,Neustadt JB,Williams JJ,et al. The lateral pillar classification of Legg-Calv6-Perthes disease[J]. J Pediatr Orthop, 1992,12(2) : 143-150.
6Little DG, Kim HK. Potential for bisphosphonate treatment in Legg-Calve- Perthes disease[J]. J Pediatr Orthop, 2011,31 (2 Suppl ) : S 182-188.
8Wiig O,Terjesen T, Svenningsen S. Prognostic factors and outcome of treatment in Perthes disease : a prospective study of 368 patients with five- year follow-up[J]. J Bone Joint Surg Br,2008,90(10) : 1364-1371.
9Chotivichit A ,Korwutthikulrangsri E ,Pomrattanamaneewong C ,et al. Core decompression with bone marrow injection for the treatment of femoral head osteonecrosis[J]. J Med Assoe Thai, 2014,97 Suppl 9:S139-143.
10Kim HK,da Cunha AM ,Browne R ,et al. How much varus is optimal with proximal femoral osteotomy to preserve the femoral head in Legg-Calve-Perthes disease?[J]. J Bone Joint Surg Am, 2011,93 (4):341-347.